TheCable1 小时
THE NEW SNAKE OIL: Antivenoms that are as useless as water
BY PAUL ECCLES, ANDJELA MILIVOJEVIC AND RACHEL SCHRAER ADDITIONAL REPORTING BY SHAFA’ATU SULEIMAN AND LAURA MARGOTTINI He ...
Vial Adaptors for Reconstitution Drug Market to Reach USD 4,146.27 by 2032, Growing at a 7. ...
The Global Vial Adaptors for Reconstitution Drug Market is poised for substantial growth, reflecting strong financial ...
Tevogen Bio CEO Congratulates RFK Jr. on His Confirmation as Secretary of the HHS; Echoes ...
Ryan Saadi, MD, MPH, Founder and CEO of Tevogen Bio (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN), a ...
Le Lézard16 小时
Pfizer's TALZENNA® in Combination with XTANDI® Improves Survival Outcomes in Metastatic ...
Pfizer Inc. today announced positive results from the Phase 3 TALAPRO-2 study of TALZENNA® (talazoparib), an oral poly ADP-ribose polymerase (PARP) inhibitor, in combination with XTANDI® (enzalutamide ...
Credence Research Inc.: Vial Adaptors for Reconstitution Drug Market to Reach USD 4,146.27 ...
The Global Vial Adaptors for Reconstitution Drug Market is poised for substantial growth, reflecting strong financial projections and industry expansion.